The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00580-w |
_version_ | 1830132719534735360 |
---|---|
author | Xiaolin Zhu Yiping Zhang Qingyu Luo Xiaowei Wu Furong Huang Tong Shu Yong Wan Hongyan Chen Zhihua Liu |
author_facet | Xiaolin Zhu Yiping Zhang Qingyu Luo Xiaowei Wu Furong Huang Tong Shu Yong Wan Hongyan Chen Zhihua Liu |
author_sort | Xiaolin Zhu |
collection | DOAJ |
first_indexed | 2024-12-17T06:39:26Z |
format | Article |
id | doaj.art-c530e42d15364e18a4f597940dd87a83 |
institution | Directory Open Access Journal |
issn | 2059-3635 |
language | English |
last_indexed | 2024-12-17T06:39:26Z |
publishDate | 2021-07-01 |
publisher | Nature Publishing Group |
record_format | Article |
series | Signal Transduction and Targeted Therapy |
spelling | doaj.art-c530e42d15364e18a4f597940dd87a832022-12-21T21:59:53ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352021-07-01611310.1038/s41392-021-00580-wThe deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIPXiaolin Zhu0Yiping Zhang1Qingyu Luo2Xiaowei Wu3Furong Huang4Tong Shu5Yong Wan6Hongyan Chen7Zhihua Liu8State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Department of Pharmacology, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of MedicineState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Collegehttps://doi.org/10.1038/s41392-021-00580-w |
spellingShingle | Xiaolin Zhu Yiping Zhang Qingyu Luo Xiaowei Wu Furong Huang Tong Shu Yong Wan Hongyan Chen Zhihua Liu The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP Signal Transduction and Targeted Therapy |
title | The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP |
title_full | The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP |
title_fullStr | The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP |
title_full_unstemmed | The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP |
title_short | The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP |
title_sort | deubiquitinase usp11 promotes ovarian cancer chemoresistance by stabilizing bip |
url | https://doi.org/10.1038/s41392-021-00580-w |
work_keys_str_mv | AT xiaolinzhu thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT yipingzhang thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT qingyuluo thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT xiaoweiwu thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT furonghuang thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT tongshu thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT yongwan thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT hongyanchen thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT zhihualiu thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT xiaolinzhu deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT yipingzhang deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT qingyuluo deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT xiaoweiwu deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT furonghuang deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT tongshu deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT yongwan deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT hongyanchen deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip AT zhihualiu deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip |